Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
+0.66%
1,047.56
+6.87
+0.66%
1,040.691,048.261,057.851,047.26
SIXC
Communications
SIXC
Communications
SIXC
+1.22%
567.18
+6.82
+1.22%
560.36560.36568.72560.36
SIXE
Energy
SIXE
Energy
SIXE
-0.10%
1,316.41
-1.28
-0.10%
1,317.691,324.291,335.361,315.26
SIXI
Industrials
SIXI
Industrials
SIXI
-1.03%
1,590.43
-16.48
-1.03%
1,606.911,611.511,621.751,587.23
SIXM
Financials
SIXM
Financials
SIXM
+1.40%
598.56
+8.28
+1.40%
590.28592.25601.18592.25
SIXR
Staples
SIXR
Staples
SIXR
+0.57%
832.66
+4.68
+0.57%
827.98828.20835.94826.74
SIXRE
Real estate
SIXRE
Real estate
SIXRE
+1.28%
199.57
+2.53
+1.28%
197.04197.04200.54197.04
SIXT
Technology
SIXT
Technology
SIXT
-1.38%
2,582.10
-36.10
-1.38%
2,618.202,638.492,649.452,581.24
SIXU
Utilities
SIXU
Utilities
SIXU
+1.20%
935.98
+11.32
+1.20%
924.66929.51938.99929.51
SIXV
Health care
SIXV
Health care
SIXV
+0.48%
1,456.52
+6.93
+0.48%
1,449.591,453.441,462.731,452.88
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0.49%
2,147.31
+10.42
+0.49%
2,136.892,149.922,166.642,146.99
C68:FRA
Crescent Biopharma Inc
€13.00
+19.27%
(+2.10) 1D
Mar 30, 6:54:48 PM GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for C68...
Open
€12.40
High
€13.00
Low
€12.40
Mkt. cap
441.60M
Avg. vol.
7.00
Volume
610.00
52-wk high
€13.00
52-wk low
€6.70
No. of employees
44
News stories
From sources across the web
About Crescent Biopharma Inc
CEO-
Employees44
Founded2024
HeadquartersWaltham, Massachusetts, United States
SectorBiotechnology
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
-
-
-
10.84M
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.63M
12.08M
20.35M
95.03M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.60M
8.95M
5.54M
7.31M
Operating expense
14.22M
21.03M
25.88M
102.34M
Total operating expenses
14.22M
21.03M
25.88M
102.34M
Operating income
-14.22M
-21.03M
-25.88M
-91.49M
Other non operating income
-
-
-
-
EBT including unusual items
-15.15M
-21.79M
-24.61M
-90.40M
EBT excluding unusual items
-15.15M
-21.79M
-24.61M
-90.40M
Income tax expense
-
-
-
2.00M
Effective tax rate
-
-
-
-2.21%
Other operating expenses
-
-
-
-
Net income
-15.15M
-21.79M
-24.61M
-92.40M
Net profit margin
-
-
-
-852.06%
Earnings per share
-
-3.72
-1.37
-4.92
Interest and investment income
188.00K
313.00K
1.28M
1.10M
Interest expense
-1.11M
-1.07M
-
-
Net interest expenses
-924.00K
-760.00K
1.28M
1.10M
Depreciation and amortization charges
-
-
-
-
EBITDA
-
-21.03M
-25.86M
-91.44M
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more